Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Systematic and mechanistic assessment of the roles of circRNAs in Alzheimer's Disease

Award Number: R21AG082109
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/15/2023
PERIOD OF PERFORMANCE END DATE: 01/31/2026

Group Awards By:

View Award Description

Systematic and mechanistic assessment of the roles of circRNAs in Alzheimer's Disease - PROJECT SUMMARY Control of RNA metabolism is emerging as a major hub for regulation in the brain. Therefore, it is not surprising that there is a strong link between perturbation of RNA metabolism and a number of neurological and neurodegenerative diseases. These include Alzheimer’s Disease (AD) in which Tau protein and Aß42 fragments have been shown to interact and/or modulate directly or indirectly RNA binding proteins and RNA metabolism in general. Circular RNAs (circRNAs) are highly abundant RNAs produced by circularization of specific exons. Interestingly, circRNAs accumulate in an age-dependent manner in neural tissues suggesting their relevance to age-related homeostasis and/or pathogenesis. Indeed, specific circRNAs accumulate in the brains of individuals with Parkinson’s and Alzheimer’s diseases. However, how these circRNAs are involved in the pathogenesis of those and other neurodegenerative diseases is largely unknown. We recently developed systems to down- or up-regulate circRNAs in Drosophila. Using these tools, we demonstrated the functionality of these molecules in vivo. We generated a resource to knock down (KD) the 110 more abundant circRNAs and found that KD of particular circRNAs results in different brain-related phenotypes. Interestingly, we identified 35 circRNAs that when knocked down alter lifespan. Further data shows that expression of some circRNAs is toxic for the aging fly, with links to aging and potentially neurodegeneration. In addition, we found that KD of some circRNAs lead to specific behavioral and motor defects, many of which are age-dependent. In addition, we observed changes in the levels of circRNAs in Drosophila models of AD or other neurogenerative diseases. Here we aim to uncover the functions and mechanisms of action of circRNAs during AD. To do so, we will use Drosophila AD models and perform a genomic screening to determine if modulation of individual circRNAs can alter the progression and outcome of the disease. Moreover, we will also test potential mechanisms by which circRNAs could alter AD including nucleation of aggregates, altering mitochondrial function, autophagy, apoptosis, and/or inflammation. In sum, the present proposal will reveal new roles of circRNAs during AD. As we will perform the experiments in a system that has high and functional levels of circRNAs (the fly CNS) the present results will be meaningful and could be later extended to mammalian models. We are aware of the limitations of the AD fly models but this is the only system in which the full extent of interaction with a large number of circRNAs can be assessed. Moreover, as we have already found that some circRNAs alter aging, the chances of success are high. This will be a pioneering work in this new and important area of research and we are confident that our findings will open a new pathway for studying the roles of circRNAs in AD. Our project builds on exciting preliminary results and the unique and constantly evolving expertise of our group.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $203,125 )
2024	2024	BRANDEIS UNIVERSITY	415 SOUTH ST	WALTHAM	MA	02453	MIDDLESEX	USA	Aging Research	000	2	1/31/2024	NON-COMPETING CONTINUATION	$182,813
2024	2024	BRANDEIS UNIVERSITY	415 SOUTH ST	WALTHAM	MA	02453	MIDDLESEX	USA	Aging Research	001	2	6/20/2024	NON-COMPETING CONTINUATION	$20,312
														Subtotal = $203,125

Issue Date FY: 2023 ( Subtotal = $243,750 )
2023	2023	BRANDEIS UNIVERSITY	415 SOUTH ST	WALTHAM	MA	02453	MIDDLESEX	USA	Aging Research	000	1	4/10/2023	NEW	$243,750
														Subtotal = $243,750

Grand Total All Awards = $446,875

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Systematic and mechanistic assessment of the roles of circRNAs in Alzheimer's Disease

Award Number: R21AG082109

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/15/2023

PERIOD OF PERFORMANCE END DATE: 01/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer